<DOC>
	<DOC>NCT00145028</DOC>
	<brief_summary>To determine Carboplatin's optimal exposures(optimal AUCs)and parameters they depend on.</brief_summary>
	<brief_title>Determination of Carboplatin's Optimal Plasmatic Exposure</brief_title>
	<detailed_description />
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Carcinoma histologically proved and which must be treated by Carboplatin, excepted weekly administered Carboplatin treatments Age &gt; 18 years Neutrophils &gt; 1500/mm3, bloodplatelets &gt; 100000/mm3 Patient with intravenous administration route for chemotherapy independent of the one used for blood samples ( for Investigators centers achieving pharmacokinetic examination) Wellinformed written consent, signed by the patient Carboplatin treatment's contraindication Patient with clinically detectable cerebral metastasis Pregnant or nursing women Patient under guardianship or trusteeship Patient whose venous status don't permit a peripheral intravenous administration route's placing (for Investigators centers achieving pharmacokinetic examination)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Neoplasms</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>optimal exposure</keyword>
	<keyword>AUC</keyword>
</DOC>